Biolife Solutions BLFS
NASDAQ BLFS
$37.08 -1.77 (-4.56%)
As of: Oct 1, 2026 · 3:43 PM EDT

Biolife Solutions (BLFS) Long-Term Deferred Tax (2026)

Updated

Biolife Solutions' Long-Term Deferred Tax was $42.23 million in Q2 2026.

Analysis

Biolife Solutions (BLFS) Long-Term Deferred Tax (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Biolife Solutions 1.90 Bn 1.57 Bn 18.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.23 Mn
API Access

Biolife Solutions Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=BLFS&period=max&api_key=YOUR_API_KEY